Quick Takeaways
- This page summarizes Jonathan E. Lim's Form 3 filing for Maze Therapeutics, Inc. (MAZE).
- 0 reported transactions and 4 derivative rows are listed below.
- Filing timestamp: 30 Jan 2025, 16:34.
Jonathan E. Lim - 30 Jan 2025 Form 3 Insider Report for Maze Therapeutics, Inc. (MAZE)
- Role
- Director
- Signature
- /s/ Courtney Phillips, as attorney-in-fact
- Issuer symbol
- MAZE
- Transactions as of
- 30 Jan 2025
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 30 Jan 2025, 16:34:12 UTC
- Previous filing
- 21 Jun 2024
- Next filing
- 05 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Jonathan E. Lim filed Form 3 for Maze Therapeutics, Inc. (MAZE) on 30 Jan 2025."
What Changed
- Previous filing in this sequence was filed on 21 Jun 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Official SEC Source
See Original Filing
Ownership activity is grounded in SEC Form 3 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MAZE | Common Stock | 20,744 | 30 Jan 2025 | Direct |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MAZE | Series A Preferred Stock | 30 Jan 2025 | Common Stock | 363,703 | City Hill, LLC | F1, F2 | |||||||
| holding | MAZE | Series B Preferred Stock | 30 Jan 2025 | Common Stock | 2,231,381 | City Hill, LLC | F2, F3 | |||||||
| holding | MAZE | Stock Option (Right to Buy) | 30 Jan 2025 | Common Stock | 5,704 | $10.42 | Direct | F4 | ||||||
| holding | MAZE | Stock Option (Right to Buy) | 30 Jan 2025 | Common Stock | 9,086 | $10.42 | Direct | F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Pursuant to the Issuer's Restated Certificate of Incorporation, each share of Series A Convertible Preferred Stock may be converted, at the option of the holder, at any time. In connection with the completion of the Issuer's initial public offering of its Common Stock, each share of Series A Convertible Preferred Stock shall automatically convert into shares of Common Stock at a ratio of 1-for- 0.1037236801. The securities have no expiration date. |
| F2 | These securities are directly held by City Hill, LLC, of which the reporting person is the managing partner. |
| F3 | Pursuant to the Issuer's Restated Certificate of Incorporation, each share of Series B Convertible Preferred Stock may be converted, at the option of the holder, at any time. In connection with the completion of the Issuer's initial public offering of its Common Stock, each share of Series B Convertible Preferred Stock shall automatically convert into shares of Common Stock at a ratio of 1-for-0.1211056427. The securities have no expiration date. |
| F4 | The option vested or vests as to 1/36th of the total award monthly, with the first tranche vesting on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |
| F5 | The option vested or vests as to 1/36th of the total award monthly, with the first tranche vesting on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |